New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CRM;JCP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
February 26, 2015
12:48 EDTJCPEarnings Preview: J.C. Penney sees Q4 SSS at high end of 2%-4% view
Subscribe for More Information
12:01 EDTJCPAppeals court revives two claims by Macy's against J.C. Penney, Reuters says
A New York appeals court has revived two claims by Macy's (M) against J.C. Penney (JCP) that accuse J.C. Penney of contract interference and unfair competition related to a Martha Stewart contract, though the appeals court reaffirmed the prior decision that Macy's did not deserve punitive damages, reports Reuters, citing court statements. Reference Link
11:58 EDTCRMSalesforce hits 52-week high after raising FY16 revenue outlook
Subscribe for More Information
11:52 EDTJCPMacy's claims against J.C. Penney to be reinstated after appeal, Bloomberg says
11:15 EDTCRMStocks with call strike movement; AAPL CRM
Subscribe for More Information
10:19 EDTCRMHigh option volume stocks
Subscribe for More Information
09:35 EDTCRMActive equity options trading on open
Subscribe for More Information
09:25 EDTCRMOn The Fly: Pre-market Movers
Subscribe for More Information
07:55 EDTCRMSalesforce.com price target raised to $80 from $75 at Credit Suisse
Subscribe for More Information
07:43 EDTCRMSalesforce.com price target raised to $80 from $70 at Canaccord
Canaccord raised its price target on Salesforce.com to $80 from $70 following its Q4 report, citing increased guidance, margin expansion, and an increase in large deal transactions. Canaccord reiterated its Buy rating on Salesforce.com shares.
07:42 EDTCRMSalesforce.com price target raised to $79 from $70 at Stifel
Stifel increased its price target on Salesforce.com after the company reported in-line results but higher than expected billings. The firm thinks the company's margins are continuing to expand and it keeps a Buy rating on the stock.
07:36 EDTJCPJ.C. Penney volatility elevated into Q4 and outlook
J.C. Penney February weekly call option implied volatility is at 168, March weekly calls are at 91, April is at 55; compared to its 26-week average of 54 according to Track Data, suggesting large near term price movement into the expected release of Q4 results today.
07:06 EDTCRMSalesforce.com guidance conservative, says Pacific Crest
Subscribe for More Information
07:05 EDTCRMSalesforce.com price target raised to $80 from $70 at Deutsche Bank
Deutsche Bank raised its price target for Salesforce.com shares to $80 after the company posted 37% constant currency billings growth in Q4. It reiterates a Buy rating on the stock.
06:38 EDTCRMSalesforce.com price target raised to $78 from $71 at Citigroup
Subscribe for More Information
February 25, 2015
18:24 EDTCRMOn The Fly: After Hours Movers
Subscribe for More Information
16:09 EDTCRMSalesforce.com FY16 EPS 67c-69c, consensus 69c
Subscribe for More Information
16:07 EDTCRMSalesforce.com sees Q1 EPS 13c-14c, consensus 15c
Subscribe for More Information
16:06 EDTCRMSalesforce.com reports Q4 EPS 14c, consensus 14c
Subscribe for More Information
15:12 EDTCRMSalesforce.com technical notes ahead of results
Shares have been trading in a range largely bound between $55 at the low and $65 at the high for the last several months. There is a bullish bias within the range. The two extremes of the range may be helpful for understanding where price could go post-earnings. A move up to and above the high at $65 would mean a potential breakout to the 52-week high and life high at $67. That high was set nearly a year ago to date. A breakout above $67 would set up a run to $70. The $70 area would be the top of the long-term price channel, projected forward in time. If the news is not as bullish as traders appear to expect, a move down to the $55 area would be possible. Support prior to that range low is at $58.92, the 50-day moving average, which could be a downside objective on a less severe disappointment. A breakdown below $55 would see next support at $52.74.
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use